Form 4 for NEO NEOGENOMICS INC
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-13 · accession 0001628280-26-002199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-15 | 2026-01-13 | NEO | Stone Warren | Pres, COO | F - Tax | $0.00 | -15.1K | 143.8K | -10% | $0 | |
| 2026-01-15 | 2026-01-13 | NEO | Stone Warren | Pres, COO | M - OptEx | $0.00 | +59.4K | 158.9K | +60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-13 | F | D | 15,127 | $0.00 | 143,759 | D | — | — | (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. |
| 2 | Common | Common Stock | 2026-01-13 | M | A | 59,382 | $0.00 | 158,886 | D | — | — | (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. |